STING1 and neoplasm: Chemotherapy, in particular, offers a compelling solution by inducing immunogenic cell death (ICD), which releases tumor-associated antigens (TAAs) and creates a pro-inflammatory environment that synergizes with STING-mediated immune activation (13–15).